Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31196 total
Upstart Holdings has just printed Q3 results, and the market's immediate verdict is a wave of target-price cuts from Wall Street and a short book that refused to cover into the news. The positioning story heading into…
OPEN fell another 3.3% on Tuesday to close at $1.74, extending a month-long slide of nearly 29% that has taken the stock to its lowest levels of the year. The timing is sharp: the company reports Q3 results on November…
Array Technologies posted a 37% gain on the week into its November 5 earnings print, and the positioning picture shifted materially from the one described in last week's note. The most striking change is in options.…
Eos Energy Enterprises reports Q3 results on 5 November with one of the most pressured lending setups in the market: nearly half the free float is short, every share in the lending pool is already lent out, and a 76.8…
Palantir Technologies dropped 11.7% over the past week to $175.40, posting its worst five-session performance in months even as analysts responded to Q3 results by raising price targets in bulk. The earnings reaction…
Harmony Biosciences has just printed Q3 results, and the positioning data tells a story of bears who built aggressively into the number and are now only partially unwinding. Short interest came into the print at close…
Rocket Companies is up 17% over the past week to $13.81, one of the strongest single-week moves in its recent history, yet short interest has not retreated. It climbed another 5.6% on the week to 157.9 million shares,…
People Incorporated reported Q3 results on November 3 and the stock bounced, closing at $38.50 on Tuesday, up 4.4% on the day and 3.2% on the week. That gain looks more striking in context: the median move across…
LMND fell 10% over the past week to close at $41.34, a move that stands in stark contrast to the median 2.4% gain across its closest peers, and it arrives with the company's Q3 results due Wednesday morning. Short…
COMPASS Pathways heads into tomorrow's results with the stock down 27% on the week, analysts cutting targets, and the market scrambling to reprice a thesis that looked very different a month ago. The magnitude of the…
Nurix Therapeutics enters November with a notable contradiction: short sellers hold 20% of the free float, yet options traders have rarely looked more bullish. Short interest at 20.2% of free float is genuinely…
Procore Technologies just reported Q3 results, and the most telling development is not what happened on the income statement but what short sellers and options traders did around it. Short interest has climbed to 12.9%…
Short sellers have been building aggressively into Hess Midstream LP, with the short position now at 11.5% of the free float, the highest level in at least a year. That figure was below 6% just five weeks ago. Over…
IGIC has just reported Q3 results, and the positioning heading into the print was about as bullish as the data ever shows for this stock. The clearest signal was in options, and it has not changed since the earlier…
Beam Therapeutics just posted its Q3 results, and the stock has gained 5.7% over the past week to $26.33, outperforming most of its gene-editing peers at a moment when the analyst community is sending sharply mixed…
BNTX barely moved last week, down 0.2%, while closest peer MRNA rallied nearly 10% and the broader mRNA-adjacent group pushed higher across the board. The gap is sharpest when you line up the peer moves. Moderna gained…
Datadog reported its Q3 numbers on November 4 and the market's verdict was swift: the stock fell 21.5% on the week to $220.52, a move that dwarfs the already-weak peer group, where FTNT dropped 30.8%, PANW fell 12.8%,…
Dynatrace dropped 26% over the past week to close at $47.03 on November 3, the steepest decline among its closest software peers, with fiscal second-quarter results due the following morning now the single reference…
Mirum Pharmaceuticals reported earnings on November 3 and walked away with a fresh wave of analyst upgrades the following morning, making the Street's response to the print the most interesting thing on the tape this…
CrowdStrike fell 8.7% over the past week to close at $244.68, reversing a large portion of the rally that had briefly pushed it above the analyst consensus target less than two weeks ago, but the cybersecurity sector…
